Light Chain Bioscience | Novimmune SA Email Format
Biotechnology ResearchGeneva, Switzerland51-200 Employees
Light Chain Bioscience, a brand of Novimmune SA, operates in the biotechnology research field with a focus on developing multi-specific antibodies that leverage light chains for their function. Based in the Geneva region of Switzerland, the company has progressed a portfolio that includes several drug candidates across preclinical and clinical stages, targeting a range of conditions. Its work centers on antibody discovery and development platforms that enable next-generation multispecific antibodies, with a track record of collaborations and partnerships aimed at advancing their programs. The organization arose from Novimmune SA, continuing its biotherapeutics focus while rebranding to emphasize its light-chain–based approach and next-generation antibody capabilities. Recent activity includes partnerships that expand the development and potential application of its bispecific antibody technology.